Generic version of OAB drug now available

Article

A generic version of the overactive bladder drug trospium chloride has received FDA approval and is now available.

A generic version of the overactive bladder drug trospium chloride has received FDA approval and is now available.

Perrigo Co. said it had previously prevailed in litigation related to the drug’s launch at both the district and appellate levels. The product has begun shipping immediately, according to the company.

Trospium, also marketed under the brand name Sanctura XR, is a once-daily medication for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency.

Related Content

PTNS therapy for OAB found durable at 3 years

 

Newer overactive bladder agent viable alternative to antimuscarinics

Related Videos
Woman talking with doctor | Image Credit: © bongkarn - stock.adobe.com
Caroline Dowling, MBBS, MS, FRACS (Urol), answers a question during a Zoom video interview
Dr. Claire S. Burton in an interview with Urology Times
Doctor talking with patient | Image Credit: © Chinnapong - stock.adobe.com
Blurred image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Alisa J. Stephens-Shields, PhD, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.